Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease

NCT00693004 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

236

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: PRX-03140
DRUG: Donepezil
DRUG: Placebo

Sponsor

Epix Pharmaceuticals, Inc.